Dexilant

Product NDC: 64764-175
11-digit product format: 647640175
Labeler code: 64764
Product ID: 64764-175_402fdd3a-6183-4a0d-85ac-61d4221fc921
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: dexlansoprazole
Dosage form: CAPSULE, DELAYED RELEASE
Route: ORAL
Labeler: Takeda Pharmaceuticals America, Inc.
Application: NDA022287
Marketing category: NDA
Marketing start: 2010-04-12
Substance: DEXLANSOPRAZOLE
Active strength: 60 mg/1
Pharmacologic classes: Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022287-001	DEXILANT	DEXLANSOPRAZOLE	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30
N022287-002	DEXILANT	DEXLANSOPRAZOLE	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N022287-001	AB
N022287-002	AB

Orange Book patents#

Current patent rows page 1 of 1 · 28 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N022287-001	8461187	2026-01-17		Drug product
N022287-001	9238029	2026-01-17		Drug product	2016-02-11
N022287-001	9011926	2026-02-24		Drug product	2015-05-01
N022287-001	8461187*PED	2026-07-17		Pediatric extension
N022287-001	7790755	2026-08-02		Drug product	2010-09-29
N022287-001	8105626	2026-09-27		Drug product	2012-02-28
N022287-001	7790755*PED	2027-02-02		Pediatric extension
N022287-001	8105626*PED	2027-03-27		Pediatric extension
N022287-001	8871273	2028-01-11		Drug product	2014-12-01
N022287-001	8173158	2030-03-17	U-949		2012-06-01
N022287-001	8173158	2030-03-17	U-950		2012-06-01
N022287-001	8173158	2030-03-17	U-951		2012-06-01
N022287-001	8173158*PED	2030-09-17		Pediatric extension
N022287-001	9233103	2032-03-05	U-1805		2016-02-11
N022287-002	8461187	2026-01-17		Drug product
N022287-002	9238029	2026-01-17		Drug product	2016-02-11
N022287-002	9011926	2026-02-24		Drug product	2015-05-01
N022287-002	8461187*PED	2026-07-17		Pediatric extension
N022287-002	7790755	2026-08-02		Drug product
N022287-002	8105626	2026-09-27		Drug product
N022287-002	7790755*PED	2027-02-02		Pediatric extension
N022287-002	8105626*PED	2027-03-27		Pediatric extension
N022287-002	8871273	2028-01-11		Drug product	2014-12-01
N022287-002	8173158	2030-03-17	U-949
N022287-002	8173158	2030-03-17	U-950
N022287-002	8173158	2030-03-17	U-951
N022287-002	8173158*PED	2030-09-17		Pediatric extension
N022287-002	9233103	2032-03-05	U-1805		2016-02-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD	2009-01-30	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL		RLD	2009-01-30	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL		RLD	2009-01-30	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL		RLD	2009-01-30	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022287-001	DEXILANT	30MG	CAPSULE, DELAYED RELEASE / ORAL		RLD	2009-01-30	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022287-002	DEXILANT	60MG	CAPSULE, DELAYED RELEASE / ORAL	AB	RLD, RS	2009-01-30	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 73 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N022287-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022287-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022287-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022287-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022287-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022287-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022287-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022287-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022287-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022287-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022287-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022287-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022287-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022287-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022287-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022287-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022287-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022287-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022287-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022287-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022287-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022287-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022287-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022287-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022287-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022287-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022287-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022287-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022287-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022287-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N022287-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022287-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022287-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022287-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022287-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022287-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022287-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022287-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022287-002	AB	1	`5aa47cf7b7d7…`

Observed Orange Book patent history#

Patent history page 1 of 48 · 1,908 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N022287-001	8461187	2026-01-17		Drug product		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-001	9238029	2026-01-17		Drug product	2016-02-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-001	9011926	2026-02-24		Drug product	2015-05-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-001	8461187*PED	2026-07-17		Pediatric extension		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-001	7790755	2026-08-02		Drug product	2010-09-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-001	8105626	2026-09-27		Drug product	2012-02-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-001	7790755*PED	2027-02-02		Pediatric extension		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-001	8105626*PED	2027-03-27		Pediatric extension		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-001	8871273	2028-01-11		Drug product	2014-12-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-001	8173158	2030-03-17	U-951		2012-06-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-001	8173158	2030-03-17	U-949		2012-06-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-001	8173158	2030-03-17	U-950		2012-06-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-001	8173158*PED	2030-09-17		Pediatric extension		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-001	9233103	2032-03-05	U-1805		2016-02-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	8461187	2026-01-17		Drug product		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	9238029	2026-01-17		Drug product	2016-02-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	9011926	2026-02-24		Drug product	2015-05-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	8461187*PED	2026-07-17		Pediatric extension		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	7790755	2026-08-02		Drug product		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	8105626	2026-09-27		Drug product		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	7790755*PED	2027-02-02		Pediatric extension		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	8105626*PED	2027-03-27		Pediatric extension		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	8871273	2028-01-11		Drug product	2014-12-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	8173158	2030-03-17	U-951			`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	8173158	2030-03-17	U-950			`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	8173158	2030-03-17	U-949			`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	8173158*PED	2030-09-17		Pediatric extension		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022287-002	9233103	2032-03-05	U-1805		2016-02-11	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022287-001	8461187	2026-01-17		Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022287-001	9238029	2026-01-17		Drug product	2016-02-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022287-001	9011926	2026-02-24		Drug product	2015-05-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022287-001	8461187*PED	2026-07-17		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022287-001	7790755	2026-08-02		Drug product	2010-09-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022287-001	8105626	2026-09-27		Drug product	2012-02-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022287-001	7790755*PED	2027-02-02		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022287-001	8105626*PED	2027-03-27		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022287-001	8871273	2028-01-11		Drug product	2014-12-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022287-001	8173158	2030-03-17	U-951		2012-06-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022287-001	8173158	2030-03-17	U-949		2012-06-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022287-001	8173158	2030-03-17	U-950		2012-06-01	`caaa826d4ba7…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N022287-001	NPP	2019-07-08	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022287-001	NPP	2019-07-08	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022287-001	NPP	2019-07-08	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022287-002	NPP	2019-07-08	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022287-002	NPP	2019-07-08	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022287-002	NPP	2019-07-08	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	N022287-001	NPP	2019-07-08	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022287-001	NPP	2019-07-08	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022287-001	NPP	2019-07-08	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022287-002	NPP	2019-07-08	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022287-002	NPP	2019-07-08	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022287-002	NPP	2019-07-08	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022287-001	NPP	2019-07-08	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022287-001	NPP	2019-07-08	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022287-001	NPP	2019-07-08	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022287-002	NPP	2019-07-08	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022287-002	NPP	2019-07-08	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022287-002	NPP	2019-07-08	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022287-001	NPP	2019-07-08	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022287-001	NPP	2019-07-08	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022287-001	NPP	2019-07-08	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022287-002	NPP	2019-07-08	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022287-002	NPP	2019-07-08	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022287-002	NPP	2019-07-08	`ea99ee380514…`

Additional Listing Data#

Finished product: Yes
Brand name base: Dexilant
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DEXLANSOPRAZOLE	60 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
UYE4T5I70X	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
833204	Internal RxNorm lookup
833213	Internal RxNorm lookup
902624	Internal RxNorm lookup
902626	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
9819f033-3bbe-442e-8e92-45fec77b237d	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
9e37788c-b1bf-42ae-aac9-b60601606144	Product name	8	20260122
1527ac37-808d-43be-a63e-74e1258dbe46	Product name	9	20250219
72065c97-63d2-e1f2-e507-59f0b1c78119	Product name	5	20250114
bed0530e-f939-4541-956b-6928a2f6404f	Product name	1	20241008
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	6	20240814
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
9fcb7a91-de07-4f00-aabf-e4d6fda403d5	Product name	8	20230322
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
9badc7be-250a-44ab-aa36-926af3f02679	Product name	1	20210527
0ec3537a-6c9b-432a-896c-b9ea8723049a	Product name	9	20200701
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
7916de40-e296-41f0-b811-6d0df1a33e2c	Product name	9	20180627
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	2	20171212
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
64764-175-00	Dexilant	7 in 1 BOTTLE	CAPSULE, DELAYED RELEASE	7	40
64764-175-01	Dexilant	4 in 1 BLISTER PACK	CAPSULE, DELAYED RELEASE	4	40
64764-175-01	Dexilant	5 in 1 TRAY	CAPSULE, DELAYED RELEASE	5	40
64764-175-02	Dexilant	30 in 1 BOTTLE	CAPSULE, DELAYED RELEASE	30	40
64764-175-11	Dexilant	10 in 1 CARTON	CAPSULE, DELAYED RELEASE	10	40
64764-175-11	Dexilant	10 in 1 BLISTER PACK	CAPSULE, DELAYED RELEASE	10	40
64764-175-19	Dexilant	1000 in 1 BOTTLE	CAPSULE, DELAYED RELEASE	1000	40
64764-175-30	Dexilant	30 in 1 BOTTLE	CAPSULE, DELAYED RELEASE	30	40
64764-175-90	Dexilant	90 in 1 BOTTLE	CAPSULE, DELAYED RELEASE	90	40

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
64764-175-30	EA - Each	64764-175	a62a3be6-3b8a-4c70-af79-0f025113de1f	1	2012-07-24
64764-175-90	EA - Each	64764-175	e3ec23ff-a658-4dea-bff3-bbc0c0fd6cec	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
dexlansoprazole	ACTIVE INGREDIENT	UYE4T5I70X	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
dexlansoprazole	ACTIVE MOIETY	UYE4T5I70X	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
aluminum oxide	INACTIVE INGREDIENT	LMI26O6933	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
carrageenan	INACTIVE INGREDIENT	5C69YCD2YJ	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
FD&C Blue No. 2	INACTIVE INGREDIENT	L06K8R7DQK	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
ferric oxide red	INACTIVE INGREDIENT	1K09F3G675	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
hydroxypropyl cellulose, low substituted	INACTIVE INGREDIENT	2165RE0K14	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
magnesium carbonate	INACTIVE INGREDIENT	0E53J927NA	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
Methacrylic Acid - Ethyl Acrylate Copolymer (1:1) Type A	INACTIVE INGREDIENT	NX76LV5T8J	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
Methacrylic Acid - Methyl Methacrylate Copolymer (1:1)	INACTIVE INGREDIENT	74G4R6TH13	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
Methacrylic Acid - Methyl Methacrylate Copolymer (1:2)	INACTIVE INGREDIENT	5KY68S2577	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
polyethylene glycol 8000	INACTIVE INGREDIENT	Q662QK8M3B	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
polysorbate 80	INACTIVE INGREDIENT	6OZP39ZG8H	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
potassium chloride	INACTIVE INGREDIENT	660YQ98I10	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
sucrose	INACTIVE INGREDIENT	C151H8M554	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
talc	INACTIVE INGREDIENT	7SEV7J4R1U	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
triethyl citrate	INACTIVE INGREDIENT	8Z96QXD6UM	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	17
dexlansoprazole	ACTIVE INGREDIENT	UYE4T5I70X	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
dexlansoprazole	ACTIVE MOIETY	UYE4T5I70X	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
aluminum oxide	INACTIVE INGREDIENT	LMI26O6933	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
carrageenan	INACTIVE INGREDIENT	5C69YCD2YJ	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
FD&C Blue No. 2	INACTIVE INGREDIENT	L06K8R7DQK	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
hydroxypropyl cellulose, low substituted	INACTIVE INGREDIENT	2165RE0K14	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
magnesium carbonate	INACTIVE INGREDIENT	0E53J927NA	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
Methacrylic Acid - Ethyl Acrylate Copolymer (1:1) Type A	INACTIVE INGREDIENT	NX76LV5T8J	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
Methacrylic Acid - Methyl Methacrylate Copolymer (1:1)	INACTIVE INGREDIENT	74G4R6TH13	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
Methacrylic Acid - Methyl Methacrylate Copolymer (1:2)	INACTIVE INGREDIENT	5KY68S2577	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
polyethylene glycol 8000	INACTIVE INGREDIENT	Q662QK8M3B	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
polysorbate 80	INACTIVE INGREDIENT	6OZP39ZG8H	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
potassium chloride	INACTIVE INGREDIENT	660YQ98I10	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
sucrose	INACTIVE INGREDIENT	C151H8M554	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
talc	INACTIVE INGREDIENT	7SEV7J4R1U	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
triethyl citrate	INACTIVE INGREDIENT	8Z96QXD6UM	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]	3
dexlansoprazole	ACTIVE INGREDIENT	UYE4T5I70X	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
dexlansoprazole	ACTIVE MOIETY	UYE4T5I70X	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
aluminum oxide	INACTIVE INGREDIENT	LMI26O6933	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
carrageenan	INACTIVE INGREDIENT	5C69YCD2YJ	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
FD&C Blue No. 2	INACTIVE INGREDIENT	L06K8R7DQK	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
hydroxypropyl cellulose	INACTIVE INGREDIENT	RFW2ET671P	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
hydroxypropyl cellulose, low substituted	INACTIVE INGREDIENT	2165RE0K14	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
magnesium carbonate	INACTIVE INGREDIENT	0E53J927NA	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
Methacrylic Acid - Ethyl Acrylate Copolymer (1:1) Type A	INACTIVE INGREDIENT	NX76LV5T8J	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
Methacrylic Acid - Methyl Methacrylate Copolymer (1:1)	INACTIVE INGREDIENT	74G4R6TH13	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
Methacrylic Acid - Methyl Methacrylate Copolymer (1:2)	INACTIVE INGREDIENT	5KY68S2577	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
polyethylene glycol 8000	INACTIVE INGREDIENT	Q662QK8M3B	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
polysorbate 80	INACTIVE INGREDIENT	6OZP39ZG8H	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
potassium chloride	INACTIVE INGREDIENT	660YQ98I10	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
sucrose	INACTIVE INGREDIENT	C151H8M554	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
talc	INACTIVE INGREDIENT	7SEV7J4R1U	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2
triethyl citrate	INACTIVE INGREDIENT	8Z96QXD6UM	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
64764-175	DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]	40	Current NDC, Legacy NDC, 9 package rows	20250223_9819f033-3bbe-442e-8e92-45fec77b237d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Dexilant	DEXLANSOPRAZOLE	Takeda Pharmaceuticals America, Inc.	9819f033-3bbe-442e-8e92-45fec77b237d	2025-02-17	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022287 application number: NDA022287 ndc (product): 64764-175
Dexlansoprazole delayed release	DEXLANSOPRAZOLE	A-S Medication Solutions	7c7698da-3cda-4301-ae93-02fb64b9c90d	2023-11-22	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022287 application number: NDA022287

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
UYE4T5I70X	DEXLANSOPRAZOLE	138530-94-6	DEXLANSOPRAZOLE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
902624	Dexilant 30 MG Delayed Release Oral Capsule	PSN	9819f033-3bbe-442e-8e92-45fec77b237d	40
902626	Dexilant 60 MG Delayed Release Oral Capsule	PSN	9819f033-3bbe-442e-8e92-45fec77b237d	40
833204	dexlansoprazole 30 MG Delayed Release Oral Capsule	PSN	9819f033-3bbe-442e-8e92-45fec77b237d	40
833213	dexlansoprazole 60 MG Delayed Release Oral Capsule	PSN	9819f033-3bbe-442e-8e92-45fec77b237d	40
902624	dexlansoprazole 30 MG Delayed Release Oral Capsule [Dexilant]	SBD	9819f033-3bbe-442e-8e92-45fec77b237d	40
902626	dexlansoprazole 60 MG Delayed Release Oral Capsule [Dexilant]	SBD	9819f033-3bbe-442e-8e92-45fec77b237d	40
833204	dexlansoprazole 30 MG Delayed Release Oral Capsule	SCD	9819f033-3bbe-442e-8e92-45fec77b237d	40
833213	dexlansoprazole 60 MG Delayed Release Oral Capsule	SCD	9819f033-3bbe-442e-8e92-45fec77b237d	40
902624	Dexilant 30 MG Delayed Release Oral Capsule	SY	9819f033-3bbe-442e-8e92-45fec77b237d	40
902626	Dexilant 60 MG Delayed Release Oral Capsule	SY	9819f033-3bbe-442e-8e92-45fec77b237d	40
902626	Dexilant 60 MG Delayed Release Oral Capsule	PSN	d62d754e-2310-4912-b022-603ae925710d	2
833213	dexlansoprazole 60 MG Delayed Release Oral Capsule	PSN	d62d754e-2310-4912-b022-603ae925710d	2
902626	dexlansoprazole 60 MG Delayed Release Oral Capsule [Dexilant]	SBD	d62d754e-2310-4912-b022-603ae925710d	2
833213	dexlansoprazole 60 MG Delayed Release Oral Capsule	SCD	d62d754e-2310-4912-b022-603ae925710d	2
902626	Dexilant 60 MG Delayed Release Oral Capsule	SY	d62d754e-2310-4912-b022-603ae925710d	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
64764-175-00	64764017500	7 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-175-00)		2010-04-12	0000-00-00	No	No	Current
64764-175-01	64764017501	5 BLISTER PACK in 1 TRAY (64764-175-01) / 4 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK	5 blister pack	2010-04-12	0000-00-00	No	No	Current
64764-175-02	64764017502	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-175-02)		2010-04-12	0000-00-00	No	No	Current
64764-175-11	64764017511	10 BLISTER PACK in 1 CARTON (64764-175-11) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK	10 blister pack	2010-04-12	0000-00-00	No	No	Current
64764-175-19	64764017519	1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-175-19)		2010-04-12	0000-00-00	No	No	Current
64764-175-30	64764017530	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-175-30)		2010-04-12	0000-00-00	No	No	Current
64764-175-90	64764017590	90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-175-90)		2010-04-12	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Dexilant	Takeda Pharmaceuticals America, Inc. \| Takeda Ireland Limited \| Takeda GmbH	2025-02-17	HUMAN PRESCRIPTION DRUG LABEL	40
Dexilant	Cardinal Health 107, LLC	2023-03-08	HUMAN PRESCRIPTION DRUG LABEL	12
Dexilant	A-S Medication Solutions	2021-06-14	HUMAN PRESCRIPTION DRUG LABEL	5
Dexilant	Physicians Total Care, Inc.	2012-02-08	HUMAN PRESCRIPTION DRUG LABEL	2